Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe.

MLA

Bogdanova, Natalia, et al. “Prevalence of the BLM Nonsense Mutation, p.Q548X, in Ovarian Cancer Patients from Central and Eastern Europe.” Familial Cancer, vol. 14, no. 1, Mar. 2015, pp. 145–49. EBSCOhost, https://doi.org/10.1007/s10689-014-9748-x.

APA

Bogdanova, N., Togo, A. V., Ratajska, M., Kluźniak, W., Takhirova, Z., Tarp, T., Prokofyeva, D., Bermisheva, M., Yanus, G. A., Gorodnova, T. V., Sokolenko, A. P., Kuźniacka, A., Podolak, A., Stukan, M., Wokołorczyk, D., Gronwald, J., Vasilevska, D., Rudaitis, V., Runnebaum, I. B., … Dörk, T. (2015). Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe. Familial Cancer, 14(1), 145–149. https://doi.org/10.1007/s10689-014-9748-x

Chicago

Bogdanova, Natalia, Alexandr V Togo, Magdalena Ratajska, Wojtek Kluźniak, Zalina Takhirova, Theresa Tarp, Darya Prokofyeva, et al. 2015. “Prevalence of the BLM Nonsense Mutation, p.Q548X, in Ovarian Cancer Patients from Central and Eastern Europe.” Familial Cancer 14 (1): 145–49. doi:10.1007/s10689-014-9748-x.